Industry Growth Insights published a new data on “Over the Counter (OTC) & Diet Supplementary Market”. The research report is titled “Over the Counter (OTC) & Diet Supplementary Market research by Types (Analgesic & Pain Relievers, Dermatological Products, Cough, Cold and Flu Products, Vitamin Supplements, Mineral Supplements, Ophthalmic Products), By Applications (Hospital, Clinic), By Players/Companies Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer, Sun Pharma, Allergan”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Over the Counter (OTC) & Diet Supplementary Market Research Report
By Type
Analgesic & Pain Relievers, Dermatological Products, Cough, Cold and Flu Products, Vitamin Supplements, Mineral Supplements, Ophthalmic Products
By Application
Hospital, Clinic
By Companies
Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer, Sun Pharma, Allergan
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
178
Number of Tables & Figures
125
Customization Available
Yes, the report can be customized as per your need.
 & Diet Supplementary Industry Outlook.svg)
Global Over the Counter (OTC) & Diet Supplementary Market Report Segments:
The global Over the Counter (OTC) & Diet Supplementary market is segmented on the basis of:
Types
Analgesic & Pain Relievers, Dermatological Products, Cough, Cold and Flu Products, Vitamin Supplements, Mineral Supplements, Ophthalmic Products
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer AG
- Merck KGaA
- Novartis
- Johnson & Johnson
- GlaxoSmithKline
- Alkem Laboratories
- Teva Pharmaceutical Industries
- Pfizer
- Sun Pharma
- Allergan
 & Diet Supplementary Market Overview.svg)
Highlights of The Over the Counter (OTC) & Diet Supplementary Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Analgesic & Pain Relievers
- Dermatological Products
- Cough, Cold and Flu Products
- Vitamin Supplements
- Mineral Supplements
- Ophthalmic Products
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Over the Counter (OTC) & Diet Supplementary Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 & Diet Supplementary Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
OTC refers to products that are sold over the counter, which means they are not prescription medications. Diet supplementary is a term used for products that are meant to supplement your diet and may not be considered medication.
Some of the key players operating in the over the counter (otc) & diet supplementary market are Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer, Sun Pharma, Allergan.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Over the Counter (OTC) & Diet Supplementary Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Over the Counter (OTC) & Diet Supplementary Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Over the Counter (OTC) & Diet Supplementary Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Over the Counter (OTC) & Diet Supplementary Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Over the Counter (OTC) & Diet Supplementary Market Size & Forecast, 2018-2028
4.5.1 Over the Counter (OTC) & Diet Supplementary Market Size and Y-o-Y Growth
4.5.2 Over the Counter (OTC) & Diet Supplementary Market Absolute $ Opportunity
Chapter 5 Global Over the Counter (OTC) & Diet Supplementary Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Type
5.2.1 Analgesic & Pain Relievers
5.2.2 Dermatological Products
5.2.3 Cough
5.2.4 Cold and Flu Products
5.2.5 Vitamin Supplements
5.2.6 Mineral Supplements
5.2.7 Ophthalmic Products
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Over the Counter (OTC) & Diet Supplementary Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Over the Counter (OTC) & Diet Supplementary Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Over the Counter (OTC) & Diet Supplementary Analysis and Forecast
9.1 Introduction
9.2 North America Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Type
9.6.1 Analgesic & Pain Relievers
9.6.2 Dermatological Products
9.6.3 Cough
9.6.4 Cold and Flu Products
9.6.5 Vitamin Supplements
9.6.6 Mineral Supplements
9.6.7 Ophthalmic Products
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Over the Counter (OTC) & Diet Supplementary Analysis and Forecast
10.1 Introduction
10.2 Europe Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Type
10.6.1 Analgesic & Pain Relievers
10.6.2 Dermatological Products
10.6.3 Cough
10.6.4 Cold and Flu Products
10.6.5 Vitamin Supplements
10.6.6 Mineral Supplements
10.6.7 Ophthalmic Products
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Over the Counter (OTC) & Diet Supplementary Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Type
11.6.1 Analgesic & Pain Relievers
11.6.2 Dermatological Products
11.6.3 Cough
11.6.4 Cold and Flu Products
11.6.5 Vitamin Supplements
11.6.6 Mineral Supplements
11.6.7 Ophthalmic Products
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Over the Counter (OTC) & Diet Supplementary Analysis and Forecast
12.1 Introduction
12.2 Latin America Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Type
12.6.1 Analgesic & Pain Relievers
12.6.2 Dermatological Products
12.6.3 Cough
12.6.4 Cold and Flu Products
12.6.5 Vitamin Supplements
12.6.6 Mineral Supplements
12.6.7 Ophthalmic Products
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Over the Counter (OTC) & Diet Supplementary Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Type
13.6.1 Analgesic & Pain Relievers
13.6.2 Dermatological Products
13.6.3 Cough
13.6.4 Cold and Flu Products
13.6.5 Vitamin Supplements
13.6.6 Mineral Supplements
13.6.7 Ophthalmic Products
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Over the Counter (OTC) & Diet Supplementary Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Over the Counter (OTC) & Diet Supplementary Market: Competitive Dashboard
14.2 Global Over the Counter (OTC) & Diet Supplementary Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer AG
14.3.2 Merck KGaA
14.3.3 Novartis
14.3.4 Johnson & Johnson
14.3.5 GlaxoSmithKline
14.3.6 Alkem Laboratories
14.3.7 Teva Pharmaceutical Industries
14.3.8 Pfizer
14.3.9 Sun Pharma
14.3.10 Allergan
